Javascript must be enabled to continue!
P1148 Transmural Improvement May Be a Practical and Acceptable Treatment Target in Crohn’s Disease
View through CrossRef
Abstract
Background
Transmural remission is associated with improved long-term outcomes in Crohn’s disease (CD), yet it is seldom achieved in routine practice. Identifying alternative therapeutic targets, such as transmural improvement, may support individualized treatment strategies.
Methods
A retrospective study was performed, including consecutive CD patients who underwent paired endoscopy and MRI enterography. Endoscopic remission was defined as SES-CD ≤3, corresponding to the absence of mucosal ulcers aside from small aphthae (<5 mm) or erosions, <50% segment involvement, and no stricture. Endoscopic improvement was defined as ≥ 50% reduction in SES-CD from baseline. Outcomes included CD-related surgery, hospitalization, steroid use, treatment change, and phenotype progression. Multivariable regression assessed predictors of adverse outcomes.
Results
A total of 411 patients were included. Transmural improvement, although inferior to transmural remission, yielded better outcomes than no transmural improvement for surgery (0.8% vs 16.3% vs 46.8), hospitalization (4.1% vs 30.8% vs 55.4), steroid use (8.3% vs 34.6% vs 51.1), treatment change (12.4% vs 51.9% vs 67.2), and phenotype progression (5.9% vs 15.4% vs 31.0) (all p ≤ 0.035). Transmural improvement reduced the risk of surgery (HR 0.294; p < 0.001), hospitalization (HR 0.465; p < 0.001), steroid use (HR 0.604; p = 0.011), treatment change (HR 0.690; p = 0.025), and phenotype progression (OR 3.332; p = 0.002). Among patients with transmural improvement, stricturing disease predicted surgery (HR 4.043; p = 0.008) and hospitalization (HR 3.704; p = 0.005).
Conclusion
Transmural improvement may be an acceptable alternative treatment target in CD patients unable to achieve transmural remission. However, in stricturing disease, transmural improvement may be insufficient, as these patients remain at higher risk for adverse outcomes.
Conflict of interest:
Dr. Tubal Bronze, Sérgio Manuel: No conflict of interest
Fernandes, Samuel Raimundo: None to declare
Rodrigues, Inês: No conflict of interest
Saraiva, Sofia: No conflict of interest
Ana Rita, Gonçalves: No conflict of interest
Ana, Valente: No conflict of interest
Correia, Luis: No conflict of interest
Oxford University Press (OUP)
Title: P1148 Transmural Improvement May Be a Practical and Acceptable Treatment Target in Crohn’s Disease
Description:
Abstract
Background
Transmural remission is associated with improved long-term outcomes in Crohn’s disease (CD), yet it is seldom achieved in routine practice.
Identifying alternative therapeutic targets, such as transmural improvement, may support individualized treatment strategies.
Methods
A retrospective study was performed, including consecutive CD patients who underwent paired endoscopy and MRI enterography.
Endoscopic remission was defined as SES-CD ≤3, corresponding to the absence of mucosal ulcers aside from small aphthae (<5 mm) or erosions, <50% segment involvement, and no stricture.
Endoscopic improvement was defined as ≥ 50% reduction in SES-CD from baseline.
Outcomes included CD-related surgery, hospitalization, steroid use, treatment change, and phenotype progression.
Multivariable regression assessed predictors of adverse outcomes.
Results
A total of 411 patients were included.
Transmural improvement, although inferior to transmural remission, yielded better outcomes than no transmural improvement for surgery (0.
8% vs 16.
3% vs 46.
8), hospitalization (4.
1% vs 30.
8% vs 55.
4), steroid use (8.
3% vs 34.
6% vs 51.
1), treatment change (12.
4% vs 51.
9% vs 67.
2), and phenotype progression (5.
9% vs 15.
4% vs 31.
0) (all p ≤ 0.
035).
Transmural improvement reduced the risk of surgery (HR 0.
294; p < 0.
001), hospitalization (HR 0.
465; p < 0.
001), steroid use (HR 0.
604; p = 0.
011), treatment change (HR 0.
690; p = 0.
025), and phenotype progression (OR 3.
332; p = 0.
002).
Among patients with transmural improvement, stricturing disease predicted surgery (HR 4.
043; p = 0.
008) and hospitalization (HR 3.
704; p = 0.
005).
Conclusion
Transmural improvement may be an acceptable alternative treatment target in CD patients unable to achieve transmural remission.
However, in stricturing disease, transmural improvement may be insufficient, as these patients remain at higher risk for adverse outcomes.
Conflict of interest:
Dr.
Tubal Bronze, Sérgio Manuel: No conflict of interest
Fernandes, Samuel Raimundo: None to declare
Rodrigues, Inês: No conflict of interest
Saraiva, Sofia: No conflict of interest
Ana Rita, Gonçalves: No conflict of interest
Ana, Valente: No conflict of interest
Correia, Luis: No conflict of interest.
Related Results
Extra-Intestinal Features of Crohn’s Disease
Extra-Intestinal Features of Crohn’s Disease
Although Crohn’s disease is a chronic inflammatory disease of the gastrointestinal tract, it can affect multiple organs behaving like a multisystem immune mediated disease. The dys...
Slow and fast changes in transmural pulmonary artery pressure in obstructive sleep apnoea
Slow and fast changes in transmural pulmonary artery pressure in obstructive sleep apnoea
Our purpose was to assess how pulmonary artery pressure changes in relation to hypoxia and oesophageal pressure during obstructive sleep apnoeas. Transmural systolic pulmonary arte...
Transmural healing is not associated with less disability than complete endoscopic mucosal healing: a prospective study in a patient with Crohn's disease
Transmural healing is not associated with less disability than complete endoscopic mucosal healing: a prospective study in a patient with Crohn's disease
Abstract
Introduction:
Crohn's disease (CD) is associated with disability by affecting physical and emotional well-being, and by altering social interactions. The impact o...
CLINICAL MANIFESTATIONS OF CROHN'S DISEASE AND SURGICAL EVALUATION OF ITS MAIN COMPLICATIONS
CLINICAL MANIFESTATIONS OF CROHN'S DISEASE AND SURGICAL EVALUATION OF ITS MAIN COMPLICATIONS
A doença de Crohn, uma enfermidade inflamatória intestinal crônica, apresenta um espectro clínico amplo, desde manifestações leves até complicações graves que podem exigir interven...
Effects of muscarinic agonists in the guinea‐pig prostate
Effects of muscarinic agonists in the guinea‐pig prostate
Summary1 The contractile response to transmural stimulation of the guinea‐pig prostate is largely due to activation of noradrenergic neurons but there is a small contribution from ...
M6A Methylation Modification–Mediated Mucosal Immune Microenvironment in Crohn's Disease
M6A Methylation Modification–Mediated Mucosal Immune Microenvironment in Crohn's Disease
Abstract
Objective
To explore the pathogenesis of Crohn's disease by revealing the relationship between m6A methylation and Crohn's disease
Methods
The GEO (GENE EXPRESSI...
P119 Perianal Crohn’s disease and the development of colorectal and anal cancer: A systematic review and meta-analysis
P119 Perianal Crohn’s disease and the development of colorectal and anal cancer: A systematic review and meta-analysis
Abstract
Background
Over the course of their disease, 15-30% of patients with Crohn's disease(CD) develop Perianal Crohn's disea...
Bacterial dysentery complicated with Crohn’s disease: A case report
Bacterial dysentery complicated with Crohn’s disease: A case report
Rationale:
Crohn’s disease is easily confused with bacillary dysentery in clinical manifestations. Crohn’s disease is a chronic disease that can involve both in...

